Equity Research, Broker Reports, and media content on Allergy Therapeutics

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Allergy Therapeutics
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Allergy Therapeutics. We currently have 180 research reports from 8 professional analysts.

Open
12.2p
Range Today
12.2/12.5p
52 Week
8.20/24.5p
Daily Volume
0.0k
# Shares
636.2m
Daily Liquidity
(0%)
Pension Liability
£9.52m
Enterprise Value
£149.8m
Market Cap
£79.5m
Latest PE (hist)
Div Yield
Date Source Announcement
11Jul19 07:00 RNS Trading update
01Jul19 07:21 EQS Hardman & Co Research: Allergy Therapeutics (AGY): Successful legal outcome removes uncertainty
01Jul19 07:16 EQS Hardman & Co Research: Oxford BioMedica (OXB): Eying up long-term value
27Jun19 07:00 RNS Successful Litigation Settlement
27Jun19 07:00 RNS Trading Statement
19Jun19 07:00 RNS Board Change
11Jun19 07:00 RNS Holdings in Company
  • Frequency of research reports

     

  • Research reports on

    Allergy Therapeutics

  • Providers covering

    Allergy Therapeutics